Acute rheumatic fever

I. Diagnosis

Modified Jones Criteria (1992) for Acute Rheumatic Fever

REQUIRE: 2 major or 1 major and 2 minor criteria and evidence of previous GAS pharyngitis.

  1. Major diagnostic criteria
    1. Carditis
    2. Polyarthritis
    3. Chorea
    4. Subcutaneous nodules
    5. Erythema marginatum
  2. Minor diagnostic criteria
    1. Fever
    2. Arthralgia
    3. Prolonged PR interval on ECG
    4. Elevated acute-phase reactants (APRs), i.e ESR and CRP
    5. Evidence of previous GAS pharyngitis:
    6. Positive throat Cx or rapid strep test or Elevated or rising streptococcal antibody titer

II. Symptoms

  1. Polyarthritis: most common symptom and often earliest (70-75%). Begins in knees and ankles, migrates to other large joints. Responds to aspirin
  2. Carditis: Most serious complication and the second most common (50%). The murmurs of acute RF are from valve regurgitation, and the murmurs of chronic RF are from valve stenosis
  3. Sydenham Chorea: 10-30%. P/W difficulty writing, involuntary grimacing, purposeless movements of the arms and legs, speech impairment, generalized weakness, and emotional lability
  4. Erythema marginatum: aka erythema annulare, occurs in 5-13%. Erythema marginatum begins as 1- to 3-cm diameter, pink-to-red nonpruritic macules or papules located on the trunk and proximal limbs but never on the face. Spreads outward to form a serpiginous ring with central clearing. Can be accentuated by warm towels/hot bath. Occurs early, remains past the resolution of other sx
  • DDx includes sepsis, drug reactions, and glomerulonephritis.

Subcutaneous nodules: Frequency has declined to 0-8%. Extensor surfaces. Firm, nontender, mobile, seveal millimeters to 1-2 cm.

  • Histo: Like Aschoff bodies observed in the heart. Subcutaneous nodules generallyoccur several weeks into the disease and resolve within a month

III. Treatment

A. Eradicate GAS infection

1. PCN 0.6 to 1.3 million Units IM x 1 or

2. Oral PCN for 10 days or

3. Erythromycin if PCN-allergic

B. Future prophylaxis

C. Treatment of symptoms, e.g. arthritis


Source

7/2/09 PANI

3/10 Rosen